Canada Biotechnology And Pharmaceutical Services Outsourcing Market Size & Outlook
Related Markets
Canada biotechnology and pharmaceutical services outsourcing market highlights
- The Canada biotechnology and pharmaceutical services outsourcing market generated a revenue of USD 913.1 million in 2024 and is expected to reach USD 1,251.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 5.5% from 2025 to 2030.
- In terms of segment, product design & development was the largest revenue generating services in 2024.
- Regulatory Affairs is the most lucrative services segment registering the fastest growth during the forecast period.
Biotechnology and pharmaceutical services outsourcing market data book summary
| Market revenue in 2024 | USD 913.1 million |
| Market revenue in 2030 | USD 1,251.4 million |
| Growth rate | 5.5% (CAGR from 2025 to 2030) |
| Largest segment | Product design & development |
| Fastest growing segment | Regulatory Affairs |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
| Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
Other key industry trends
- In terms of revenue, Canada accounted for 1.9% of the global biotechnology and pharmaceutical services outsourcing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biotechnology and pharmaceutical services outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,251.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biotechnology And Pharmaceutical Services Outsourcing Market Scope
Biotechnology And Pharmaceutical Services Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Heidelberg Materials AG | View profile | 51000 | Berliner Strasse 6, Heidelberg, BW, Germany, 69120 | https://www.heidelbergmaterials.com |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbiologics.com/ |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Canada biotechnology and pharmaceutical services outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Product design & development was the largest segment with a revenue share of 34.62% in 2024. Horizon Databook has segmented the Canada biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Government of Canada, Canada has one of the highest numbers of biotechnology companies across the globe focused on human health, giving the country a strong record of achievement in biopharmaceuticals.
In addition, the notable trend toward outsourcing drug development & production to CROs, CMOs, and CDMOs and leveraging their expertise & specialized services is fueling market growth in Canada.
Moreover, the rising technological innovations, growing demand for personalized medicine, and increasing number of clinical trials in Canada are some of the major factors expected to improve the demand for biotechnology & pharmaceutical services outsourcing.
Reasons to subscribe to Canada biotechnology and pharmaceutical services outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada biotechnology and pharmaceutical services outsourcing market databook
-
Our clientele includes a mix of biotechnology and pharmaceutical services outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Canada biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada biotechnology and pharmaceutical services outsourcing market size, by services, 2018-2030 (US$M)
Canada Biotechnology And Pharmaceutical Services Outsourcing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
